Description
Cost: Non-members: $65 | Member: $35 | Student: $15
The intersection of pharmacology and longevity science has revealed exciting possibilities for repurposing existing medications to support healthy aging and extend health span. Among the most promising agents are GLP-1 receptor agonists and metformin, originally developed for managing type 2 diabetes. Emerging evidence suggests these medications exert profound effects beyond glycemic control, targeting fundamental aging processes such as inflammation, mitochondrial dysfunction, and cellular repair mechanisms. This presentation will explore the evidence supporting the use of these medications and others in anti-aging and longevity, with a focus on their potential mechanisms of action.
Dawn Ipsen, PharmD is owner and pharmacist of Clark’s Compounding Pharmacy in Bellevue, WA and Kusler’s Compounding Pharmacy in Snohomish, WA. Dawn graduated from the University of Washington with a Doctorate of Pharmacy in 2001 where she received the Dean’s Outstanding Service Award. Dawn is a Full Fellow of the Alliance for Compounding Pharmacy and the American College of Apothecaries. She holds memberships with the Washington State Pharmacy Association. She is a Clinical Instructor for the University of Washington School of Pharmacy and an Affiliate Faculty Member for Bastyr University. She is a Pharmacist Preceptor for Washington State and teaches Doctorate of Pharmacy students. Dawn also served on the Professional Compounding Centers of America (PCCA) Advisory Counsel and Chair of the WSPA Compounding Special Interest Group. She was named UW School of Pharmacy 2020 Distinguished Alumni Award for Excellence in Pharmacy Practice and most recently the WSPA Rod Schafer Pharmacy Leadership Award for 2023. Dawn has presented on the topic of pharmaceutical compounding and LDN to healthcare provider, patient, and peer groups. She is dedicated to helping her community find solutions to medication problems through personalized medication therapies.
**This presentation is worth 1 Category 1 CE for Washington-licensed NDs.**
Originally presented May 2nd - 4th, 2025, at WANP's CONNECT 2025 conference.
